166 related articles for article (PubMed ID: 27838426)
1. 5-Aminolaevulinic Acid-Induced Fluorescence in Primary Central Nervous System Lymphoma.
Evers G; Kamp M; Warneke N; Berdel W; Sabel M; Stummer W; Ewelt C
World Neurosurg; 2017 Feb; 98():375-380. PubMed ID: 27838426
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic Diagnosis Using 5-Aminolevulinic Acid in 41 Biopsies for Primary Central Nervous System Lymphoma.
Yamamoto T; Ishikawa E; Miki S; Sakamoto N; Zaboronok A; Matsuda M; Akutsu H; Nakai K; Tsuruta W; Matsumura A
Photochem Photobiol; 2015 Nov; 91(6):1452-7. PubMed ID: 26277101
[TBL] [Abstract][Full Text] [Related]
3. 5-Aminolevulinic Acid-Induced Fluorescence in Cerebellar Primary Central Nervous System Lymphoma: A Case Report and Literature Review.
Yamamoto J; Kitagawa T; Akiba D; Nishizawa S
Turk Neurosurg; 2015; 25(5):796-800. PubMed ID: 26442550
[TBL] [Abstract][Full Text] [Related]
4. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients.
Kiesel B; Millesi M; Woehrer A; Furtner J; Bavand A; Roetzer T; Mischkulnig M; Wolfsberger S; Preusser M; Knosp E; Widhalm G
Neurosurg Focus; 2018 Jun; 44(6):E7. PubMed ID: 29852770
[TBL] [Abstract][Full Text] [Related]
5. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
6. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
8. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
[TBL] [Abstract][Full Text] [Related]
9. Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival?
Kamp MA; Munoz-Bendix C; Mijderwijk HJ; Turowski B; Dibué-Adjei M; von Saß C; Cornelius JF; Steiger HJ; Rapp M; Sabel M
J Neurooncol; 2019 Feb; 141(3):547-553. PubMed ID: 30535595
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches.
Hunt MA; Jahnke K; Murillo TP; Neuwelt EA
Neurosurg Focus; 2006 Nov; 21(5):E3. PubMed ID: 17134119
[TBL] [Abstract][Full Text] [Related]
12. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study.
Nabavi A; Thurm H; Zountsas B; Pietsch T; Lanfermann H; Pichlmeier U; Mehdorn M;
Neurosurgery; 2009 Dec; 65(6):1070-6; discussion 1076-7. PubMed ID: 19934966
[TBL] [Abstract][Full Text] [Related]
13. Low dose 5-aminolevulinic acid: Implications in spectroscopic measurements during brain tumor surgery.
Haj-Hosseini N; Richter JC; Hallbeck M; Wårdell K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):209-14. PubMed ID: 25818546
[TBL] [Abstract][Full Text] [Related]
14. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI.
Lin FH; Zhang XH; Zhang J; He ZQ; Duan H; Ke C; Sai K; Jiang XB; Al-Nahari F; Xi SY; Mou YG
J Neurooncol; 2018 Sep; 139(3):757-765. PubMed ID: 30117022
[TBL] [Abstract][Full Text] [Related]
15. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-guided resection of gliomas.
Cortnum S; Laursen RJ
Dan Med J; 2012 Aug; 59(8):A4460. PubMed ID: 22849976
[TBL] [Abstract][Full Text] [Related]
17. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas.
Stockhammer F; Misch M; Horn P; Koch A; Fonyuy N; Plotkin M
Acta Neurochir (Wien); 2009 Nov; 151(11):1377-83. PubMed ID: 19639250
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
[TBL] [Abstract][Full Text] [Related]
19. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
20. Is it a glioblastoma? In dubio pro 5-ALA!
Kamp MA; Santacroce A; Zella S; Reichelt DC; Felsberg J; Steiger HJ; Cornelius JF; Sabel M
Acta Neurochir (Wien); 2012 Jul; 154(7):1269-73. PubMed ID: 22576268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
